Wockhardt, which recently undertook a debt restructuring scheme, has signed an agreement to divest its non-core nutritional business to Abbott, a global healthcare company. Sources said the deal was worth close to $130...
Wockhardt may sell non-core biz to raise Rs 790 cr
Wockhardt has set a target to mobilise Rs 790 crore by selling its non-core businesses as part of its corporate debt restructuring (CDR) plan, which its lenders approved last week, nearly two-and-a-half months after the...
Piramal to demerge healthcare & financial services business.
Business tycoon Ajay Piramal-led Piramal Enterprises is looking to demerge its healthcare and financial services businesses to grow the unrelated divisions separately, marking an important turn in the legacy of the...
Raheja Corp buys 30 acres from Cabot for Rs 210 cr
In one of the biggest land deals in the Mumbai Metropolitan Region (MMR) this year, real estate developer K Raheja Corp has bought 30 acres in the Ghansoli area of Navi Mumbai for Rs 210 crore or Rs 7 crore an acre...
November 2015
- Tide Acquirer - Hostile Takeover : Cover Story - Piramal Abbott Story : Deal Impact - Dell EMC - Biggest Tech Merger - Prabhat Dairy IPO : Strategy - Legal Aspects of E-Commerce : Part I - Ashish Kashyap : Leadership...
LUPIN ACQUIRES US GENERICS FIRM GAVIS FOR $880 MILLION
Pharma industry is growing very fast mainly through the inorganic route and given below are some major deals in last five years. RanbaxySun TOP PHARMA DEALS IN INDIA Target Acquirer Deal Size ($bn) Year Ranbaxy Daiichi...